Who Owns Dr. Reddy's Laboratories-adr (RDY)? 13F Institutional Holders (Q2 2026)

RDY ranks #2601 out of 37501 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

RDY is a top-conviction position for Aikya Investment Management Ltd — at 36.1% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in RDY belongs to Robeco Institutional Asset Management B.V., but the position matters far more to Aikya Investment Management Ltd, who has 36.1% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Robeco Institutional Asset Management B.V. has added to its RDY position for two straight quarters, increasing it by $76.4M to reach $261.1M today.

Jim Simons has trimmed its RDY position for two straight quarters, cutting it by $9.4M while still holding $106.5M.

RDY is up 0.3% today, and institutions have been net buyers of $89.2M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

RDY closed its latest fiscal year with net income of $452.0M.

• Profitable — net income of $452.0M in the latest fiscal year
• Revenue declined 98.9% year over year
• Net income declined year over year, from $57.2B to $452.0M
• Generated $607.0M in positive operating cash flow
• Current ratio of 1.80x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.52x equity — within a conventional range